SEC Filings | Allogene Therapeutics

Filing date	Description	Form	View
Nov 02, 2023	Quarterly report which provides a continuing view of a company's financial position	10-Q	0001737287-23-000091.pdf 0001737287-23-000091.rtf 0001737287-23-000091.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Oct 15, 2018	Post effective amendment to proposed Securities Act Rule 462(b) registration statement	POS462B	0001193125-18-299286.pdf 0001193125-18-299286.rtf 0001193125-18-299286.xls View HTML
Mar 14, 2024	POSASR	POSASR	0001193125-24-067984.pdf 0001193125-24-067984.rtf 0001193125-24-067984.xls View HTML
Oct 15, 2018	POS EX	POS EX	0001193125-18-299225.pdf 0001193125-18-299225.rtf 0001193125-18-299225.xls View HTML
Apr 24, 2019	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0001193125-19-115774.pdf 0001193125-19-115774.rtf 0001193125-19-115774.xls View HTML
Apr 23, 2020	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0001737287-20-000021.pdf 0001737287-20-000021.rtf 0001737287-20-000021.xls View HTML
Apr 22, 2021	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0001737287-21-000013.pdf 0001737287-21-000013.rtf 0001737287-21-000013.xls View HTML
Apr 26, 2022	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0001737287-22-000026.pdf 0001737287-22-000026.rtf 0001737287-22-000026.xls View HTML
Apr 24, 2023	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0001737287-23-000041.pdf 0001737287-23-000041.rtf 0001737287-23-000041.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Apr 23, 2024	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0001737287-24-000032.pdf 0001737287-24-000032.rtf 0001737287-24-000032.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.